These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 7017734)
21. Leprechaunism: an inherited defect in a high-affinity insulin receptor. Elsas LJ; Endo F; Strumlauf E; Elders J; Priest JH Am J Hum Genet; 1985 Jan; 37(1):73-88. PubMed ID: 3883764 [TBL] [Abstract][Full Text] [Related]
22. Receptors for insulin-like growth factors and growth effects of multiplication-stimulating activity (rat insulin-like growth factor II) in rat embryo fibroblasts. Adams SO; Nissley SP; Kasuga M; Foley TP; Rechler MM Endocrinology; 1983 Mar; 112(3):971-8. PubMed ID: 6295749 [TBL] [Abstract][Full Text] [Related]
23. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism. Nakae J; Kato M; Murashita M; Shinohara N; Tajima T; Fujieda K J Clin Endocrinol Metab; 1998 Feb; 83(2):542-9. PubMed ID: 9467572 [TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor II binding and action in human fetal fibroblasts. Conover CA; Rosenfeld RG; Hintz RL J Cell Physiol; 1987 Dec; 133(3):560-6. PubMed ID: 2961773 [TBL] [Abstract][Full Text] [Related]
25. Insulin and insulin-like growth factor I regulate the same biological functions in HEP-G2 cells via their own specific receptors. Verspohl EJ; Maddux BA; Goldfine ID J Clin Endocrinol Metab; 1988 Jul; 67(1):169-74. PubMed ID: 2837499 [TBL] [Abstract][Full Text] [Related]
26. A homozygous kinase-defective mutation in the insulin receptor gene in a patient with leprechaunism. Takahashi Y; Kadowaki H; Momomura K; Fukushima Y; Orban T; Okai T; Taketani Y; Akanuma Y; Yazaki Y; Kadowaki T Diabetologia; 1997 Apr; 40(4):412-20. PubMed ID: 9112018 [TBL] [Abstract][Full Text] [Related]
27. Cell culture studies on patients with extreme insulin resistance. I. Receptor defects on cultured fibroblasts. Podskalny JM; Kahn CR J Clin Endocrinol Metab; 1982 Feb; 54(2):261-8. PubMed ID: 7033276 [No Abstract] [Full Text] [Related]
28. Fibroblasts from a leprechaun patient have defects in insulin binding and insulin receptor autophosphorylation. Maassen JA; Klinkhamer MP; van der Zon GC; Sips H; Möller W; Krans HM; Lindhout D; Beemer FA Diabetologia; 1988 Aug; 31(8):612-7. PubMed ID: 2851471 [TBL] [Abstract][Full Text] [Related]
29. Insulin-stimulated glucose transport in cultured fibroblasts from normal and noninsulin-dependent (type II) diabetic human subjects. Berhanu P; Tsai P; Olefsky JM J Clin Endocrinol Metab; 1982 Dec; 55(6):1226-30. PubMed ID: 6752171 [TBL] [Abstract][Full Text] [Related]
30. Purified multiplication-stimulating activity from rat liver cell conditioned medium: comparison of biological activities with calf serum, insulin, and somatomedin. Smith GL; Temin HM J Cell Physiol; 1974 Oct; 84(2):181-92. PubMed ID: 4474180 [No Abstract] [Full Text] [Related]
31. Ten-year improvement of insulin resistance and growth with recombinant human insulin-like growth factor 1 in a patient with insulin receptor mutations resulting in leprechaunism. de Kerdanet M; Caron-Debarle M; Nivot S; Gaillot T; Lascols O; Fremont B; Bonaure M; Gie S; Massart C; Capeau J Diabetes Metab; 2015 Sep; 41(4):331-337. PubMed ID: 25465274 [TBL] [Abstract][Full Text] [Related]
32. Impaired insulin binding and excess glucose transport in fibroblasts from a patient with leprechaunism. Elsas LJ; Longo N Enzyme; 1987; 38(1-4):184-93. PubMed ID: 3440445 [TBL] [Abstract][Full Text] [Related]
33. [A case of leprechaunism with extreme insulin resistance due to a primary defect in insulin receptors]. Goji K; Takata Y; Kobayashi M Nihon Naibunpi Gakkai Zasshi; 1985 Sep; 61(9):924-35. PubMed ID: 3910462 [TBL] [Abstract][Full Text] [Related]
34. In vitro studies of insulin resistance in patients with lipoatrophic diabetes. Evidence for heterogeneous postbinding defects. Magré J; Reynet C; Capeau J; Blivet MJ; Picard J Diabetes; 1988 Apr; 37(4):421-8. PubMed ID: 3288531 [TBL] [Abstract][Full Text] [Related]
35. Protein synthesis and breakdown rates associated with the insulin resistance of fibroblasts from patients with leprechaunism. Ballard FJ; Read LC; Gunn JM J Clin Endocrinol Metab; 1985 Dec; 61(6):1146-51. PubMed ID: 3902869 [TBL] [Abstract][Full Text] [Related]
36. Insulin stimulation of aminoisobutyric acid transport in human skin fibroblasts is mediated through both insulin and type I insulin-like growth factor receptors. Chaiken RL; Moses AC; Usher P; Flier JS J Clin Endocrinol Metab; 1986 Nov; 63(5):1181-5. PubMed ID: 2944911 [TBL] [Abstract][Full Text] [Related]
37. Insulin-mediated pseudoacromegaly in a patient with severe insulin resistance: association of defective insulin-stimulated glucose transport with impaired phosphatidylinositol 3-kinase activity in fibroblasts. Kausch C; Bergemann C; Hamann A; Matthaei S Exp Clin Endocrinol Diabetes; 1999; 107(2):148-54. PubMed ID: 10320056 [TBL] [Abstract][Full Text] [Related]
38. Endogenous insulin-like growth factor (IGF) binding proteins cause IGF-1 resistance in cultured fibroblasts from a patient with short stature. Tollefsen SE; Heath-Monnig E; Cascieri MA; Bayne ML; Daughaday WH J Clin Invest; 1991 Apr; 87(4):1241-50. PubMed ID: 1707060 [TBL] [Abstract][Full Text] [Related]
39. Insulin-like growth factor-1 and insulin resistance in skeletal muscles of adult and old rats. Dardevet D; Sornet C; Attaix D; Baracos VE; Grizard J Endocrinology; 1994 Mar; 134(3):1475-84. PubMed ID: 8119189 [TBL] [Abstract][Full Text] [Related]
40. Human insulin receptors expressed in insulin-insensitive mouse fibroblasts couple with extant cellular effector systems to confer insulin sensitivity and responsiveness. Hofmann C; White MF; Whittaker J Endocrinology; 1989 Jan; 124(1):257-64. PubMed ID: 2462489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]